elaborator
elaborator facilitates exploration and analysis of laboratory data from clinical trials to identify treatment-related changes and potential safety signals.
Key Features:
- Analysis types: Supports three analysis types: identification of frequently occurring changes in laboratory values, examination of treatment-related changes, and detection of changes that exceed normal reference ranges.
- Safety signal and hypothesis generation: Analyzes patterns and anomalies in laboratory data to flag potential safety signals and generate hypotheses for follow-up analyses.
- R integration: Implemented in R and distributed as an R package available on CRAN at https://cran.r-project.org/package=elaborator.
- Data transformation and visualization: Transforms raw laboratory data into summary analyses and visualizations for review across multiple visits and treatment groups.
Scientific Applications:
- Clinical trial laboratory review: Evaluation of multiple laboratory parameters across visits and treatment arms to monitor biochemical and hematological changes.
- Safety monitoring: Identification of treatment-emergent or out-of-range laboratory changes that may indicate adverse events or safety signals.
- Regulatory submission support: Generation of summarized laboratory analyses suitable for inclusion in submissions to health authorities.
- Exploratory research: Hypothesis generation for further analyses or integration with additional data sources to investigate observed laboratory patterns.
Methodology:
Laboratory data are extracted from clinical databases and pre-processed locally, then input into elaborator for analysis performed using R (package available on CRAN).
Topics
Details
- License:
- GPL-3.0
- Cost:
- Free of charge
- Tool Type:
- library
- Operating Systems:
- Mac, Linux, Windows
- Programming Languages:
- R
- Added:
- 11/27/2021
- Last Updated:
- 11/27/2021
Operations
Publications
Janitza S, Majumder M, Mendolia F, Jeske S, Kulmann H. elaborator: A Novel App for Insights into Laboratory Data of Clinical Trials. Therapeutic Innovation & Regulatory Science. 2021;55(6):1220-1229. doi:10.1007/s43441-021-00318-4. PMID:34196957.
PMID: 34196957